Review on Mefenamic Acid Transdermal Patches
International Journal of Advanced Research in Science Communication and Technology · 16.11.2026 · 84
DOI: 10.48175/ijarsct-40810 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advanced Research in Science Communication and Technology, online erschienen am 16.11.2026. Verfasst von Ms. Pratiksha B. Bhosale und 2 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Primary dysmenorrhea is a menstrual problem. It happens when the uterus cramps a lot during periods. This pain comes from much prostaglandin being made in the body. Mefenamic acid is a drug used to ease pain. It is a nonsteroidal -inflammatory drug or NSAID When taken by mouth it can upset the stomach and cause other side effects A better way might be to deliver the drug through the skin. This is called delivery. One way to do this is with matrix-type patches. These patches use materials like HPMC, PVP and ethyl cellulose. They also include things that help the drug pass through the skin like menthol and peppermint oil. This review talks about how to make these patches how to test them what’s good about them what problems they have and what could come next. The focus is, on acid transdermal patches.
Zitieren
APA
Bhosale, M. P. B., Chandanshiv, M. V. V., & Kanse, P. K. (2026). Review on Mefenamic Acid Transdermal Patches. International Journal of Advanced Research in Science Communication and Technology, 84. https://doi.org/10.48175/ijarsct-40810
Vancouver
Bhosale MPB, Chandanshiv MVV, Kanse PK. Review on Mefenamic Acid Transdermal Patches. International Journal of Advanced Research in Science Communication and Technology. 2026:84. doi:10.48175/ijarsct-40810
BibTeX
@article{Bhosale2026,
author = {Bhosale, Ms. Pratiksha B. and Chandanshiv, Ms. Vaishnavi V. and Kanse, Prof. Krunal},
title = {Review on Mefenamic Acid Transdermal Patches},
journal = {International Journal of Advanced Research in Science Communication and Technology},
year = {2026},
pages = {84},
doi = {10.48175/ijarsct-40810}
}
EUVIMED